HAART and HCV infection

被引：0

作者：

不详

机构：

来源：

AIDS PATIENT CARE AND STDS | 1998年 / 12卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：646 / 646

页数：1

共 50 条

[21] Impact of HAART on liver histology of HIV/HCV coinfected patients [J].

De Bona, A ;

Sitia, G ;

Uberti-Foppa, C ;

Galli, L ;

Ciuffreda, D ;

Gallotta, G ;

Paties, C ;

Lazzarin, A .

JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2003, 17 (02) :195-197

[22] Hcv genotypes and pediatric HCV infection [J].

Bortolotti, F ;

Resti, M ;

Verucchi, G ;

Nebbia, G ;

Giacchino, R ;

Marazzi, MG ;

Marcellini, M ;

Barbera, C ;

Maggiore, G ;

Bartolacci, S ;

Guido, M .

JOURNAL OF HEPATOLOGY, 2004, 40 :137-137

[23] HIV-infection, HAART and hyperlipidaemia [J].

Hirsch, HH ;

Battegay, M .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (19) :1051-1054

[24] Opportunistic infection prophylaxis in the era of HAART [J].

Hewitt, RG .

INFECTIONS IN MEDICINE, 1997, 14 (09) :683-&

[25] THE INFLUENCE OF HAART ON THE EFFICACY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN THERAPY FOR THE TREATMENT OF CHRONIC HCV INFECTION IN HIV-POSITIVE INDIVIDUALS [J].

Vogel, M. ;

Ahlenstiel, G. ;

Hintsche, B. ;

Fenske, S. ;

Trein, A. ;

Lutz, T. ;

Schuermann, D. ;

Stephan, C. ;

Khaykin, P. ;

Bickel, M. ;

Mayr, C. ;

Baumgarten, A. ;

Buggisch, P. ;

Klinker, H. ;

John, C. ;

Goelz, J. ;

Staszewski, S. ;

Rockstroh, J. K. .

EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (03) :102-111

[26] The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive individuals [J].

M Vogel ;

G Ahlenstiel ;

B Hintsche ;

S Fenske ;

A Trein ;

T Lutz ;

D Schürmann ;

C Stephan ;

P Khaykin ;

M Bickel ;

C Mayr ;

A Baumgarten ;

P Buggisch ;

H Klinker ;

C John ;

J Gölz ;

S Staszewski ;

JK Rockstroh .

European Journal of Medical Research, 15 (3)

[27] Lack of effect of HCV viral load and HCV genotype on immune response after starting HAART. [J].

Antonucci, G ;

Lepri, AC ;

Girardi, E ;

Capobianchi, MR ;

Solmone, M ;

Carletti, F ;

De Luca, A ;

Vincenti, A ;

Monforte, AD .

HEPATOLOGY, 2002, 36 (04) :556A-556A

[28] Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype [J].

Caudai, C ;

Pianese, M ;

Zacchini, F ;

Toti, M ;

Zazzi, M ;

Valensin, PE .

JOURNAL OF CLINICAL VIROLOGY, 2005, 32 (02) :151-155

[29] HIV/HCV coinfection ups risk of liver toxicity during HAART [J].

Reactions Weekly, 2010, 1300 (1) :2-2

[30] Patients infected with HIV/HCV and the liver injury as a side effect of HAART [J].

Dragovic, G. J. ;

Jevtovic, D. .

JOURNAL OF CLINICAL VIROLOGY, 2006, 36 :S190-S190

← 1 2 3 4 5 →